cbdMD, Inc. (YCBD)
0.488
-0.02
(-4.11%)
USD |
NYAM |
Aug 24, 16:00
0.4986
+0.01
(+2.17%)
After-Hours: 20:00
cbdMD Enterprise Value : 5.522M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 5.522M |
| August 21, 2026 | 5.754M |
| August 20, 2026 | 5.711M |
| August 19, 2026 | 5.544M |
| August 18, 2026 | 5.321M |
| August 17, 2026 | 5.377M |
| August 14, 2026 | 5.608M |
| August 13, 2026 | 6.378M |
| August 12, 2026 | 6.745M |
| August 11, 2026 | 6.600M |
| August 10, 2026 | 6.389M |
| August 07, 2026 | 6.378M |
| August 06, 2026 | 6.386M |
| August 05, 2026 | 6.656M |
| August 04, 2026 | 6.300M |
| August 03, 2026 | 6.428M |
| July 31, 2026 | 5.732M |
| July 30, 2026 | 5.333M |
| July 29, 2026 | 5.533M |
| July 28, 2026 | 5.655M |
| July 27, 2026 | 5.877M |
| July 24, 2026 | 6.078M |
| July 23, 2026 | 6.503M |
| July 22, 2026 | 6.50M |
| July 21, 2026 | 6.464M |
| Date | Value |
|---|---|
| July 20, 2026 | 6.428M |
| July 17, 2026 | 6.432M |
| July 16, 2026 | 6.956M |
| July 15, 2026 | 7.212M |
| July 14, 2026 | 7.408M |
| July 13, 2026 | 7.679M |
| July 10, 2026 | 8.849M |
| July 09, 2026 | 9.102M |
| July 08, 2026 | 8.435M |
| July 07, 2026 | 8.300M |
| July 06, 2026 | 8.012M |
| July 02, 2026 | 7.712M |
| July 01, 2026 | 7.655M |
| June 30, 2026 | 7.579M |
| June 29, 2026 | 5.125M |
| June 26, 2026 | 5.074M |
| June 25, 2026 | 5.157M |
| June 24, 2026 | 4.717M |
| June 23, 2026 | 4.769M |
| June 22, 2026 | 5.022M |
| June 18, 2026 | 5.335M |
| June 17, 2026 | 4.989M |
| June 16, 2026 | 4.790M |
| June 15, 2026 | 4.811M |
| June 12, 2026 | 4.977M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tilray Brands, Inc. | 763.07M |
| Organogenesis Holdings, Inc. | 374.86M |
| Guardian Pharmacy Services, Inc. | 2.345B |
| Nektar Therapeutics | 1.967B |
| Elite Pharmaceuticals, Inc. | 278.03M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.127M |
| Revenue (Quarterly) | 5.554M |
| Total Expenses (Quarterly) | 6.681M |
| EPS Diluted (Quarterly) | -0.1129 |
| Gross Profit Margin (Quarterly) | 50.03% |
| Profit Margin (Quarterly) | -20.30% |
| Earnings Yield | -63.34% |
| Normalized Earnings Yield | -63.34 |